Metastatic hormone-sensitive prostate cancer (mHSPC) often has an abbreviated, aggressive disease course. This article presents a case of mHSPC quickly pro
Vorasidenib is a new promising clinical treatment for gliomas. However, this recent breakthrough in the treatment of brain tumors is only a snapshot of a…
Lung cancer kills more people globally than any other cancer [1]. In the United States, it is responsible for more cancer-related deaths than breast, prostate,…
Childhood cancer treatment is challenging, with certain cancer types proving particularly difficult to treat. Although researchers have made significant progress, the outlook for children with…
What is Chevron deference, how did it come to be, and what were the implications for FDA? Chevron deference was established by the 1984 Supreme…
At Oxford University Press, we’re proud to publish groundbreaking and impactful research on anesthesiology and pain medicine. Follow the links below to bro
Adam E. Singer, MD, PhD, details how he selects between the available TKI/IO combinations and the only dual immunotherapy regimen for patients with RCC.
Researchers developed a predictive model to assess endometrial hyperplasia and cancer risk in patients with recurrent abnormal uterine bleeding. Learn more.
In the phase III HARMONi-2 study conducted in China, presented at the IASLC 2024 World Conference on Lung Cancer, the bispecific antibody ivonescimab was compared…
#ASTRO24 Speed Mentoring extends a warm invitation to all Annual Meeting registrants eager to connect with ASTRO leaders and gain valuable insights for both career…
In FRα-positive, platinum-resistant ovarian cancer, mirvetuximab soravtansine showed improvements in progression-free survival, overall response rate, and overall survival.
